Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06089239 · ClinicalTrials.gov registry record · NA

Choosing Wisely: De-implementing Fall Prevention Alarms in Hospitals

A NA study of Accidental Fall and Patient Safety, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
20
Study locations

NCT06089239: Recruiting NA study of Accidental Fall and Patient Safety, sponsored by University of Florida.

NCT06089239 is a NA study of Accidental Fall and Patient Safety that is actively recruiting participants, run by University of Florida. The registered enrollment target is 300 participants, above the 230-participant average among 9 other Accidental Fall trials with a reported enrollment target (30% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06089239, a NA study of Accidental Fall and Patient Safety, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
20
Study locations

Study Summary

This is a Hybrid II de-implementation study to reduce use of fall prevention alarms in hospitals. The intervention consists of tailored, site-specific approaches for three core implementation strategies: education, audit/feedback and opinion leaders. Hospital units will be randomized to low-intensity or high-intensity coaching for the implementation of the tailored strategies.

Primary Outcome

Number of Patients in a study unit with fall prevention alarm activated divided by the number of patients evaluated. This is assessed monthly and is expressed as the proportion of patients assessed with fall prevention alarm activated. This is not a time to event outcome. This measure will be recorded monthly for 30 months during both baseline and intervention periods.

Interventions

  • OTHER High Intensity Coaching
  • OTHER Low Intensity Coaching

Study Locations (20)

California

  • PIH Health Downey Hospital - Downey
  • El Camino Health - Los Gatos - Mountain View
  • University of California Davis Medical Center - Sacramento

New Jersey

  • Hunterdon Medical Center - Flemington
  • Raritan Bay Medical Center - New Brunswick
  • Greenwich Hospital - River Vale

Illinois

  • OSF Saint Anthony's Health Center - Alton
  • Central DuPage Hospital - Winfield

Indiana

  • Hendricks Regional Health - Danville
  • IU Health North Hospital - Indianapolis

Ohio

  • Grant Medical Center - Columbus
  • Barberton Hospital - Uniontown

Oregon

  • Kaiser Westside Medical Center - Hillsboro
  • Kaiser Permanente - Sunnyside Medical Center - Woodburn

Florida

  • Lakeland Regional Medical Center - Lakeland

Massachusetts

  • UMass Memorial Health Harrington - Southbridge

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2023-10-01
Est. Completion 2026-08-31
Phase NA
University of Florida

1,106 total trials

What NCT06089239 shows while recruiting

NCT06089239 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 230-participant average among 9 other Accidental Fall trials with a reported enrollment target (30% higher).

The record links to 5 conditions, with Accidental Fall appearing as the primary indexed condition, and to 2 interventions - of which High Intensity Coaching is the first listed.

NCT06089239 names 20 study sites across 12 states, led by California, New Jersey, Illinois.

Frequently Asked Questions

What is clinical trial NCT06089239 about?

NCT06089239 is a clinical study titled "Choosing Wisely: De-implementing Fall Prevention Alarms in Hospitals". This is a Hybrid II de-implementation study to reduce use of fall prevention alarms in hospitals. The intervention consists of tailored, site-specific approaches for three core implementation strategies: education, audit/feedback and opinion leaders. Hospital units will be randomized to low-intensit...

What is the current status of trial NCT06089239?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-10-01. Estimated completion is 2026-08-31.

What conditions does trial NCT06089239 study?

This clinical trial studies the following conditions: Accidental Fall, Patient Safety, Hospital Acquired Condition, Clinical Alarms, Mentoring.

What interventions are being tested in trial NCT06089239?

The interventions under investigation include: High Intensity Coaching (OTHER), Low Intensity Coaching (OTHER).

Who is sponsoring clinical trial NCT06089239?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06089239 being conducted?

This trial has 20 study locations across California, Florida, Illinois, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Accidental Fall

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06089239's enrollment target sits among peer trials

300 4th of 9 higher than 6 of 9 other Accidental Fall trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Accidental Fall trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06089239, the US trial registry maintained by the National Library of Medicine. NCT06089239 (mid enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.